CS logo
small CS logo
CIONC - Centro Integrado de Oncologia de Curitiba

Curitiba, Brazil
Doctor in Curitiba, State of Paraná
Rua Desembargador Vieira Cavalcanti, 1152 - Mercês, Curitiba - PR, 80810-050

About CIONC - Centro Integrado de Oncologia de Curitiba


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at CIONC - Centro Integrado de Oncologia de Curitiba


During the past decade, CIONC - Centro Integrado de Oncologia de Curitiba conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CIONC - Centro Integrado de Oncologia de Curitiba" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at CIONC - Centro Integrado de Oncologia de Curitiba


According to Clinical.Site data, the most researched conditions in "CIONC - Centro Integrado de Oncologia de Curitiba" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Paroxysmal Nocturnal Hemoglobinuria" (2 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "CIONC - Centro Integrado de Oncologia de Curitiba" in a lesser frequency.

Clinical Trials Intervention Types at CIONC - Centro Integrado de Oncologia de Curitiba


Most popular intervention types in "CIONC - Centro Integrado de Oncologia de Curitiba" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Crovalimab" (2 trials) and "Eculizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at CIONC - Centro Integrado de Oncologia de Curitiba


The vast majority of trials in "CIONC - Centro Integrado de Oncologia de Curitiba" are 10 trials for "All" genders and 3 trials for "Male" genders.

Clinical Trials Status at CIONC - Centro Integrado de Oncologia de Curitiba


Currently, there are NaN active trials in "CIONC - Centro Integrado de Oncologia de Curitiba". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CIONC - Centro Integrado de Oncologia de Curitiba, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CIONC - Centro Integrado de Oncologia de Curitiba, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Departments of CIONC - Centro Integrado de Oncologia de Curitiba


CIONC - Centro Integrado de Oncologia de Curitiba has several departments that took part in Clinical trials: "Centro Integrado de Oncologia de Curitiba" - 3 trials